Overview
Watchlist
Equities
Crypto
Soon
Popular
Home
Equities
KAPA
Fundamentals

Kairos Pharma, Ltd.

KAPA

Chart
Fundamentals
Soon
Sentiment
Soon
Options

Revenue

0.00
0.000.00%
-

Assets

7.94M
▲2.17M▲37.60%
3 Months Change

Liabilities

992.00k
▼-680.00k▼-40.67%
3 Months Change

Free Cash Flow

0.00
0.000.00%
-

Revenue/Cost Of Revenue

Net Profit/Loss

Assets/Liabilities

Cash Flows

Earnings Per Share

Outstanding Shares

Recent Quarterly and Annual Filings

2024-10-10
Form 8-K
ID: 0001493152-24-040780
2024-10-04
Form 8-K
ID: 0001493152-24-039586
2024-09-27
Form 8-K
ID: 0001493152-24-038590
2024-09-24
Form 8-K
ID: 0001493152-24-037958
2024-09-17
Form 8-K
ID: 0001493152-24-036855